首页> 外文会议>World biomaterials congress >Encapsulation of proteins in micro- and nano-hydrogel carrier systems for controlled drug delivery
【24h】

Encapsulation of proteins in micro- and nano-hydrogel carrier systems for controlled drug delivery

机译:用于受控药物递送的微型和纳米水凝胶载体系统中蛋白质的封装

获取原文

摘要

Introduction: Therapeutic proteins like antibodies or signaling proteins have a high potential for pharmaceutical applications. Drug delivery systems are needed to protect these proteins from in-vivo degradation. Furthermore, the proteins are able to induce unwanted side effects. A local administration close to the diseased area and a slow drug release can minimize these effects. Hydrogels provide a protein friendly environment and can have good biocompatibility. Therefore they are well suited as drug delivery systems. Diffusion and/or degradation are the main release mechanism. The relation between network structure and release was studied for bulk hydrogels and micro gels. Furthermore the in vitro and in-vivo release was studied and compared. Materials and Methods: Hydroxyethyl starch was modified with polyethylene glycolmethacrylate HES-PEGMA, which can be photochemically cross-linked in aqueous solution in order to obtain hydrogels or injectable hydrogel microspheres. The release was investigated and correlated with the mesh size. Green fluorescent protein (GFP) loaded hydrogels have been analyzed by fluorescence methods with two-photon excitation. Via fluorescence anisotropy the inner rotational motions can be studied. Fluorescence recovery after photo-bleaching (FRAP) gives information about the translational diffusion. In vitro release rates were compared with in vivo release rates employing fluorescently labelled proteins and an IVIS?-system. Furthermore, a nanogel system prepared from chitosan and tripolyphosphate (TPP) was investigated regarding entrapment efficiency and release of signaling proteins. Fig.1: Chemical structure of the HES derivatives Fig. 2: Bulk hydrogels and injectabie micro particles were prepared from the HES derivatives Results and Discussion: The mesh size of the hydrogel network can be adjusted via the degree of substitution and the polymer concentration. The bulk hydrogels and the micro particles have similar structures and release profiles when prepared from the same polymer and concentration. The results of the fluorescence anisotropy suggest an unrestricted GFP rotation within the hydrogel, while the FRAP measurements indicate that translational mobility of GFP is restricted in the hydrogel. The comparison of in vitro and in vivo release rates indicates a good comparability depending on the acceptor medium used in the in vitro experiments. The chitosan/TPP nanoparticles are well suited to deliver biologically active BMP2. Conclusions: Hydrogels as micro- or nanoparticles are well suited for delivery of therapeutic proteins. By adjusting the preparation methods the drug release can be tailored.
机译:介绍:抗体或信号蛋白等治疗蛋白具有高潜力的药物应用。需要药物递送系统以保护这些蛋白质免于体内降解。此外,蛋白质能够诱导不需要的副作用。接近患病区域和缓慢药物释放的局部管理可以最大限度地减少这些效果。水凝胶提供蛋白质友好的环境,可以具有良好的生物相容性。因此,它们非常适合作为药物递送系统。扩散和/或降解是主要释放机制。研究了网络结构与释放之间的关系,用于散装水凝胶和微凝胶。此外,研究并比较了体外和体内释放。材料和方法:用聚乙二醇乙基丙烯酸乙酸酯HEA-PEGMA改性羟乙基淀粉,其可以在水溶液中光学地交联,以获得水凝胶或注射水凝胶微球。研究释放并与网格尺寸相关。通过具有双光子激发的荧光方法分析了绿色荧光蛋白(GFP)加载的水凝胶。通过荧光各向异性,可以研究内旋转运动。光漂白(FRAP)后的荧光回收给出了关于平移扩散的信息。将体外释放速率与使用荧光标记的蛋白质和IVIS的体内释放率进行比较。此外,研究了由壳聚糖和三聚磷酸盐(TPP)制备的纳米凝胶系统关于引起的抑制效率和信号传导蛋白的释放。图1:HES衍生物的化学结构图2:由HES衍生物的结果制备散装水凝胶和injectabie微粒,讨论:水凝胶网络的网格尺寸可以通过取代度和聚合物浓度来调节。当由相同的聚合物和浓度制备时,散装水凝胶和微粒具有相似的结构和释放型材。荧光各向异性的结果表明水凝胶内的不受限制的GFP旋转,而FRAP测量表明,在水凝胶中受到GFP的平移迁移率。体外和体内释放速率的比较表明,取决于在体外实验中使用的受体培养基的良好可比性。壳聚糖/ TPP纳米颗粒非常适合于递送生物活性BMP2。结论:水凝胶作为微型或纳米颗粒非常适合于递送治疗蛋白质。通过调节制备方法,可以量身定制药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号